A version of this article was originally published on High Existence, and The Third Wave.
Depression, despite affecting millions worldwide, is still a condition that we don’t fully understand.
In fact, we understand it so poorly that typical pharmaceutical treatments indiscriminately target whole neurochemical systems, resulting in unstable effectiveness and a host of side-effects.
Up to 44% of people suffering from depression have not found relief from typical antidepressant therapies. Even patients who find some form of relief from the usual prescribed antidepressants need frequent doses, sometimes causing unpleasant side-effects, and these drugs often lose their effectiveness after several years of treatment.
But where pharmaceuticals are failing, psychedelics could be a new hope.
This was originally published on The Third Wave – you can read the original article here.
The past few months has seen an explosion of research into the therapeutic potential of ayahuasca, the traditional psychoactive brew used by indigenous South American peoples for generations. It’s now looking highly compelling that doses of the plant-based drink have antidepressant qualities, and could also be used to combat addiction and PTSD.
Earlier last year, the announcement that scientists had discovered a potential mechanism for ayahuasca’s antidepressant properties was met with great anticipation. Researchers reported that under laboratory conditions several compounds found in ayahuasca could encourage the growth of new brain cells. Since that announcement, we’ve been excited about getting our hands on the full study!
I know, it’s been a while! I’m sorry! I’ve been busy working for The Third Wave and other ventures… the psychedelic movement is constantly gaining ground these days.
This latest (ghost-written) article of mine is intended to explain why we need to change the way we treat mental health issues, and how psychedelics could be the catalyst for a paradigm shift in mental health therapy.
Read it here!
It’s been a while since the last post here at The Psychedelic Scientist! I’ve been busy working for The Third Wave, a site that offers advice and resources about psychedelics and microdosing.
It’s an exciting time in the psychedelic movement, as more people are coming out and describing how experiences with psychedelics have shaped their lives.
In my most recent article, I hear from some of the many people who microdose with psychedelics in order to treat a mental health condition – in this case, adult ADHD.
I hope you enjoy it – and consider checking out the other resources at The Third Wave.
It’s been over fifty years since Timothy Leary, Ralph Metzner and Richard Alpert wrote “The Psychedelic Experience.” It was intended to be a psychedelic manual for the first generation of Western mind-explorers; people who desperately lacked a cultural background for their psychedelic journeys.
Unsurprisingly, this half-century old book has lost some of its applicability in modern psychedelic culture.
Stepping into the void is occultist and academic Julian Vayne, who has just released “Getting Higher” – a manual of psychedelic ceremony for the modern psychonaut. Here’s my review of this hallucinogenic handbook.
I’ve been thinking a lot recently about the enormous stigma that surrounds heroin.
Even people within the drug-using community who detest prohibition will often be heard saying something like “Yeah, legalise everything… but not heroin. Never heroin.“
Why is this the case? Is there evidence to support the view of heroin as the most harmful, addictive drug around?
This article was originally written for The Third Wave.
The tragic death of Jake Cawte near Adelaide in Australia had only barely hit the press before the finger was pointed at ayahuasca.
Jake was shot by his twin brother Luke at their family home, using one of their father’s weapons. Despite Luke’s previous issues with mental health, it was their brief encounter with ayahuasca that has, without any basis in fact, been blamed for this act of violence.
Next week is Drug and Alcohol Awareness Week at the University of Manchester. As a student there, I’ve written this piece for the Mancunion newspaper, highlighting the need for harm reduction initiatives that protect our students.
Please read and share to promote safer drug use and potentially save lives!
I wrote this article for The Third Wave, where it originally appeared, as a response to an opinion piece in the New York Times from skeptical clinical psychiatrist Richard Friedman. I think it can help address the typical arguments that come from people of anti-psychedelic bias. Enjoy!
A recent article in the New York Times, penned by clinical psychiatrist Richard Friedman, attempts to scare his audience into thinking that LSD might not be a good treatment for depression, despite a barrage of recent studies suggesting otherwise. Friedman appears to be of the opinion that it would be wrong to offer these drugs to sufferers of disease; even though there is no evidence of harm from LSD or psilocybin when given in a clinical setting, and despite the growing body of evidence of the efficacy of these drugs in treating mental health conditions.
Friedman himself mentions the debilitating nature of depression; between a third and one-half of all patients will never find relief from conventional treatments. Hundreds of millions suffer worldwide, and hundreds of thousands commit suicide every year. Most of those sufferers don’t have access to the expensive treatments most commonly handed out by psychiatrists in the developed world.
I’ve spoken a lot on The Psychedelic Scientist about the neurobiological basis of consciousness. I’ve written about how scientific research into psychedelics is helping us piece together how consciousness works. By understanding exactly how psychedelics alter our brain function, we come closer to understanding how consciousness is constructed in our brains, but, as I’ve tried to make clear in my posts, all this fascinating research doesn’t solve the ‘hard problem’ of consciousness – that is, why does consciousness exist at all?
Figuring out what parts of our brain correlate to our experiences, or precisely what organisation of information is required to elicit consciousness, will not solve the hard problem: “Why are we even experiencing any of this in the first place?”
I’ve faced a fair amount of criticism that my posts focus too much on the neurobiological basis of consciousness (let’s call it the ‘soft problem’) – so I think now’s a good time to address the philosophers and psychonauts who want to know what the subjective psychedelic experience can tell us about solving the hard problem.
So let’s leave the research behind for a minute and talk about non-reductionism, idealism, and a psychedelic universe.